Results 161 to 170 of about 123,274 (290)

On the adrenal subcellular distibution of 3H-ACTH [PDF]

, 1968
Margoulies, M., Müller, O. A., Scriba, Peter Christian   +2 more
core   +1 more source

Type 2 diabetes subphenotypes are associated with differential outcomes after metabolic and bariatric surgery: An international multicentre retrospective cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Type 2 diabetes (T2D) is characterized by its clinical heterogeneity. Newly described T2D subphenotypes, each with distinct metabolic and co‐morbidity risk profiles, may enable a more personalized care. This study examined whether these subphenotypes can predict outcomes in patients undergoing metabolic and bariatric surgery (MBS ...
Adisa Poljo, Jakob J. Reichl, Lars Kollmann, Piotr Kalinowski, Aleksandra Frankowska, Michał Grąt, Eleni A. Felinska, Ulrike Heger, Stefan Kopf, Donna Noeva, Christopher Tuffs, Matthias Hepprich, Eleonora Seelig, Ralph Peterli, Marko Kraljević, Jennifer M. Klasen, Beat P. Müller, Romano Schneider, Adrian T. Billeter   +18 more
wiley   +1 more source

Lipid droplets beyond storage: Cellular metabolic modulator in the diabetic heart (Review). [PDF]

Int J Mol Med
Liang Y, Fan X, Geng X, Jia Y, Shang W, Sun X, Ge J, Ye G, Zhu B, Zhang Z, Kang Y, Shan X, Zhang J.   +12 more
europepmc   +1 more source

Growth differentiation factor 15 mitigates lipotoxic steatosis by preserving mitochondrial morphodynamics and augmenting fatty acid oxidation in hepatocytes and liver organoids

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Growth differentiation factor 15 (GDF15) has emerged as a promising metabolic regulator with hepatoprotective properties in metabolic dysfunction‐associated steatotic liver disease (MASLD), yet its underlying mechanisms remain elusive.
Jia Li, Qi Zhou, Mengmeng Xia, Yakun Li, Junyu Wang, Manon Buist‐Homan, Vincent E. de Meijer, Hans Blokzijl, Klaas Nico Faber, Han Moshage   +9 more
wiley   +1 more source

Cytosolic Versus Lysosomal Lipolysis in Adipose Tissue: Opposing Roles in Cardiometabolic Disease. [PDF]

Arterioscler Thromb Vasc Biol
Yeh YS, Huang J, Liu Z, Cosme C, Zhang X, Razani B.   +5 more
europepmc   +1 more source

Associations of obesity, systemic inflammation, and hyperinsulinemia with the incidence of non‐communicable chronic disease and mortality: A prospective cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Obesity, systemic inflammation, and hyperinsulinemia are all features of metabolic syndrome and frequently occur together. We aimed to evaluate the association of body mass index (BMI) with incident non‐communicable chronic disease (NCD) or all‐cause mortality, independent of C‐reactive protein (CRP) and fasting insulin.
Natasha Wiebe, Stephanie Thompson, Peter Stenvinkel, Aminu Bello, Matthew T. James, Marcello Tonelli   +5 more
wiley   +1 more source

Perilipins: Current perspectives on the role in cardiovascular diseases. [PDF]

iScience
Zhang Y, Zhan J, Qiu Z, Tian H, Yang H, Lu K, Xia Z.   +6 more
europepmc   +1 more source

An international consensus on screening and monitoring early‐stage type 1 diabetes: A roadmap to European implementation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Type 1 diabetes (T1D) is a chronic autoimmune disease that results in loss of insulin‐secreting pancreatic β‐cells in the islets of Langerhans. A diagnosis of T1D is typically associated with children and adolescents, yet half of all diagnoses of T1D are made in adults.
Sufyan Hussain, Timothy Tree, Chantal Mathieu, Tomasz Klupa, Anna‐Kaisa Tuomaala, Maartje de Wit, Olga Kordonouri, Katarina Braune, Jaivir Pall, Luis Castano, Rachel E. J. Besser, Júlia Galhardo, Francesca Ulivi, Emanuele Bosi, Uroš Bogdanovic, Coralie Alabert, Tadej Battelino   +16 more
wiley   +1 more source

Possible ARDS Following Cosmetic Lipolysis: A Case Report Urging Caution in Aesthetic Medicine. [PDF]

Am J Case Rep
Phan TT, Tran AT, Dinh QM, Trinh TH, Vu VG.   +4 more
europepmc   +1 more source

Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) arises from dysregulated interactions between nutrient delivery, adipose tissue lipid handling and liver lipid metabolism, which collectively coalesce to drive inflammatory signalling leading to metabolic dysfunction‐associated steatohepatitis (MASH) and fibrosis. Recent clinical
Evangelia E. Tsakiridis, Gregory R. Steinberg   +1 more
wiley   +1 more source